American Society for Clinical Oncology’s Annual Meeting: Summary of Rare Cancer Findings
jarmoluk / Pixabay

American Society for Clinical Oncology’s Annual Meeting: Summary of Rare Cancer Findings

According to a story from currentargus.com, the annual meeting of the American Society for Clinical Oncology, which takes place in Chicago, is the largest convergence dedicated to cancer research in…

Continue Reading American Society for Clinical Oncology’s Annual Meeting: Summary of Rare Cancer Findings
Help Spread a Smile for National Cleft and Craniofacial Awareness Month
https://pixabay.com/en/smiley-wink-funny-laugh-emoticon-2091035/

Help Spread a Smile for National Cleft and Craniofacial Awareness Month

July is National Cleft & Craniofacial Awareness & Prevention Month! Cleft and craniofacial conditions affect thousands of infants, children, teens and adults in the US each year. Some are born with…

Continue Reading Help Spread a Smile for National Cleft and Craniofacial Awareness Month
Schooling Advocacy for Students with Disabilities: ULF Family Conference
Source: Pixabay.com

Schooling Advocacy for Students with Disabilities: ULF Family Conference

Last month at the United Leukodystrophy Foundation’s Family Conference, special education teacher Sharon Bergfeld, MASE, LBSI, LBSII, led a break out session on Student with Disability/Schooling Advocacy. The session provided…

Continue Reading Schooling Advocacy for Students with Disabilities: ULF Family Conference
Natural Killer Cells May Be Useful For Predicting How Patients Respond to Certain Immunotherapies, According to Recent Research
allinonemovie / Pixabay

Natural Killer Cells May Be Useful For Predicting How Patients Respond to Certain Immunotherapies, According to Recent Research

A recent study, published here in the journal Nature Medicine and used as the source for this article, has found that certain kinds of cells may be useful for predicting…

Continue Reading Natural Killer Cells May Be Useful For Predicting How Patients Respond to Certain Immunotherapies, According to Recent Research

A Phase 3 Study of an Experimental Gene Therapy for Oculopharyngeal Muscular Dystrophy Will Take Place, Axovant Says

An experimental gene therapy program (called AXO-AAV-OPMD) being developed for the treatment of oculopharyngeal muscular dystrophy has been licensed with exclusive global rights to Axovant Sciences from Benitec Biopharma. There…

Continue Reading A Phase 3 Study of an Experimental Gene Therapy for Oculopharyngeal Muscular Dystrophy Will Take Place, Axovant Says
A Phase 3 Study Has Shown Encouraging Results for an Investigational Treatment for Dravet Syndrome
jniittymaa0 / Pixabay

A Phase 3 Study Has Shown Encouraging Results for an Investigational Treatment for Dravet Syndrome

Zogenix, Inc has announced the top-line results from a Phase 3 study of the investigational drug ZX008 (low-dose fenfluramine hydrochloride) for the treatment of young patients with Dravet syndrome. The…

Continue Reading A Phase 3 Study Has Shown Encouraging Results for an Investigational Treatment for Dravet Syndrome